PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ESTRIOL”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 361 records · Page 20Linked to original sources
PubMed1978

Improved liquid chromatographic determination of placental estriol in urine.

Placental estriol in urine can be determined, after enzymatic hydrolysis, by liquid chromatography. A single-step extraction technique results in rapid processing with minimal sample manipulation. Analytical recovery of estriol added to urine was 96 to 106%. Day-to-day precision (CV), established by 10 replicate analyses at a mean concentration of 15.9 mg of estriol per liter, was 3.7%.

Chromatography, High Pressure Liquid↗
PubMed1980

Estriol-induced dose-dependent DNA synthesis in normal human mammary epithelium in vitro.

Normal human adult resting mammary gland explants were cultured during 7 days. The influence of hormones on DNA synthesis was assessed by autoradiography after incubation with tritiated-thymidine. Estriol was added to the medium at 3 different concentrations. With 0.01 ng/ml the labeling index remained at the level observed in the controls in the basic unenriched medium. A 10- and 100-fold increase of estriol elicited a transient, significant and dose-related increase of DNA synthesis on the 2nd day of organ culture. Estriol gave a qualitatively different profile of DNA synthesis than estradiol at 1.0 ng/ml. The results are compared with the effect of progesterone.

Breast↗
PubMed1979

Improved radioimmunoassay of urinary estriol.

We report a rapid double-antibody radioimmunoassay for urinary estriol. Advantages over other current methods include: (a) 30-min hydrolysis; (b) total incubation time, 55 min; (c) assay unaffected by urinary glucose; (d) no degradation of estriol evident during hydrolysis; (e) superior (85%) analytical recovery of estriol conjugates; (f) linear standard curve by logit-log extrapolation; (g) good correlation (r = 0.83) with total estrogen determination by a generally accepted colorimetric method; (h) only 20 muL of urine required; and (i) the detection range is 1.9 to 100.5 mg/24-h urine.

Cross Reactions↗
PubMed1993

[Transvaginal administration of estriol in postmenopausal urogynecological disorders].

The Authors carried out an open, non-controlled clinical trial in order to evaluate the clinical efficacy of estriol administered by the vaginal route (0.0125% cream) in cystourethropathic diseases caused by estrogenic insufficiency. All the 45 patients recruited (mean age 51.6 years) had been in menopause from 6 to 24 months; all of them have been treated with 0.5 mg estriol daily for 2 weeks; furthermore the treatment has been continued with the same dose of the hormone for the following 4 weeks but using an alternating daily administration. Among the parameters taken into consideration for the evaluation of the patients, a urodynamic examination has been also included. The final results have been considered very satisfactory showing a very significant improvement concerning every urodynamic test. Similar results have been obtained considering the symptomatologic point of view. On the basis of these results, the Authors concluded that estriol vaginal cream formulation represents a valuable therapeutical possibility in the treatment of patients affected by urogynecological diseases caused by estrogenic insufficiency in post-menopausal conditions.

Dose-Response Relationship, Drug↗
PubMed1977

Hormonal studies in pregnancy. II. Unconjugated estriol in maternal peripheral vein, cord vein, and cord artery serum at delivery in pregnancies complicated by intrauterine growth retardation.

The levels of unconjugated estriol in maternal vein serum during labor, cord artery serum, and cord vein serum were measured in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. The mean level of unconjugated estriol in maternal vein serum was significantly lower in the intrauterine growth-retarded group than in the normals (p less than 0.001). The mean estriol level in cord vein was lower only in the most severely growth-retarded subgroup as compared to the normal. There was no difference seen in the cord artery values among the groups.

Delivery, Obstetric↗
PubMed1976

Rapid radioimmunoassay of total urinary estriol.

We describe a radioimmunoassay for total urinary estriol in pregnancy. A 25-mul aliquot of the urine specimen is acid hydrolyzed, neutralized, and diluted before assay. We use rabbit antisera against estriol-6-(O-carboxymethyl)oxime/bovine serum albumin and ammonium sulfate precipitation at room temperature. Results are unaffected by glucose or methenamine mandelate, a urinary tract antiseptic. Using semi-automatic pipetting equipment, one laboratory technologist can complete 50 assays within 8 h. This technique is both reliable and convenient and should decrease the expense of routine estriol assays.

Colorimetry↗
PubMed1988

Isolated familial adrenocorticotropin deficiency: prenatal diagnosis by maternal plasma estriol assay.

We report on a brother and sister with adrenal insufficiency due to isolated adrenocorticotropin hormone deficiency discovered in the neonatal period. The first-born, a male infant, died; pathological findings suggested bilateral adrenal hypoplasia transmitted as an autosomal recessive trait. Plasma estriol levels were assayed during the mother's next pregnancy. The prenatal diagnosis allowed immediate and effective management of the second affected child. The supplementary evidence from the endocrine findings, unavailable on her brother, enabled us to make a diagnosis of isolated central ACTH deficiency. As the defect was found in infants of both sexes in the same family, it is in all likelihood transmitted as an autosomal recessive trait. We consider it important for genetic counselling to perform autopsies on all newborn infants whose death has no apparent cause. Maternal plasma estriol assays during pregnancy can help diagnose fetal adrenal insufficiency, whether the defect is central or adrenal.

Adrenal Insufficiency↗
PubMed1978

Rapid assays of urinary estriol in pregnant women.

Two devices designed for rapid assay of urinary estriol, the E3 KIT and E3 HAIR KIT, were evaluated using urine samples taken from pregnant women. Additionally, the clinical application of these devices in pregnancy management was examined. Correlations were high between an established method and the E3 KIT method (r = 0.819, p less than 0.001) and between the E3 HAIR KIT method and the E3 KIT method ( r = 0.936, p less than 0.01). E3 HAIR KIT assays showing E3 values of less than 20 microgram/ml (positive at 100-fold dilution of the urine) after the 36th week of pregnancy suggested fetoplacental dysfunction and indicated that more detailed tests were required. The E3 KIT, which provided rapid quantitative assay of urinary estriol, was capable of measuring 10 samples in approximately 3 hours. The E3 HAIR KIT provided semiquantitative assays of 10 samples in 2 hours. The speed, simplicity, and accuracy of the E3 HAIR KIT indicates its high clinical value as a prospective large-scale screening method for fetoplacental function.

Estriol↗
PubMed1987

The relation between saliva estriol levels in pregnancy and infant birth weight.

Specimens of saliva were obtained from 106 women with normal pregnancies and from 42 women, whose children turned out to small for dates (birthweight below the 10th centile). Saliva estriol was highly significantly (P less than 0.0001) decreased in the group with a newborn with a birthweight below the 10th centile (500 +/- 340 ng/ml, mean +/- SD) when compared with the group with infants whose birthweight was over the 10th centile (813 +/- 449 ng/ml). Estriol determination in saliva seems to be a simple, non invasive method of aiding the detection of fetal growth retardation.

Estriol↗
PubMed1976

Free and sulfoconjugated dehydroepiandrosterone, cyclic adenosime-3',5'-monophosphate, and free estriol in maternal and cord blood.

When free DHEA, its sulfatide, and sulfate were assayed in maternal plasma as well as in umbilical cord arterial and venous plasma, rather high concentrations were found in either fraction from cord arterial plasma, reflecting the fetal contribution not only of free DHEA and DHEA sulfate, but also of the lipophile steroid sulfatide. Since high DHEA levels were associated with elevated c-AMP concentrations, a certain interrelationship of both parameters is indicated. In the course of delivery, a rapid decrease of free estriol in maternal plasma was observed. Higher concentration of free estriol in umbilical venous plasma pointed at its placental biosynthesis from fetal precursors.

Cyclic AMP↗
PubMed1977

Plasma unconjugated estriol values in high-risk pregnancy.

The usefulness of plasma estriol concentrations in the management of high-risk pregnancy is controversial. In this study, serial plasma unconjugated estriol (E3) concentrations determined by radioimmunoassay were evaluated in 321 patients with high-risk pregnancy for correlation with fetal and neonatal performance. A plasma E3 concentration of 4 ng. per milliliter or less in late pregnancy correlated significantly with low one-and five-minute Apgar scores and selected neonatal problems in pregnancies complicated by chronic hypertension and intrauterine growth retardation, with a similar trend for pregnancies complicated by moderate and severe pre-eclampsia. Most perinatal deaths in the study were associated with acute problems which began during labor and delivery, or fetal death occurred before early intervention was practical. Therefore, the perinatal mortality rate is not likely to be influenced by the use of E3 values, and the perinatal mortality rate is not a realistic measure of the usefulness of plasma E3 values in management of high-risk pregnancy. Low plasma E3 values were not always ominous, and for this reason it is suggested that clinical indications and the results of other tests for fetal-placental function be considered along with plasma E3 values in the selection of patients for early delivery to reduce the possibility of inappropriate intervention.

Adult↗
PubMed1977

Comparison of uterotrophic and vascular effects of estradiol-17beta and estriol in the mature organism.

Estradiol-17beta (E2) has been considered the most potent of the natural estrogens in terms of uterine growth and vasodilatation. As a result of studies of uterine growth in rodents, estriol (E3) has been considered an "impeded" estrogen. In this study, direct comparisons of the actions of E2 and E3 on the sheep uterus were made in nonpregnant, oophorectomized ewes by using bilateral uterine artery catheters and electromagnetic flow transducers. Intra-arterial injections of E2 or E3 had equal growth-promoting and vascular effects. There were slight but statistically significant differences in the time course of vasodilatation. Estriol induced a more prolonged dilatation than did estradiol.

Animals↗
PubMed1980

Progesterone, 17-hydroxyprogesterone, estradiol, and estriol in late pregnancy and labor.

Levels of progesterone, 17 alpha-hydroxyprogesterone, estradiol, and estriol were measured in serial plasma samples collected from 30 uncomplicated pregnancies during the last eight weeks of gestation. From another group of 27 uncomplicated pregnancies, blood samples were collected during the second stage of labor and the same steroids were measured. Progesterone, 17-hydroxyprogesterone, and estradiol levels were highest during the last one to three weeks prior to the onset of labor, whereas estriol concentration increased progressively. The levels of these steroids during the second stage of labor were statistically not different from those just preceding labor. It is concluded that the onset of human labor is not associated with marked changes in the maternal levels of any of these steroids.

Estradiol↗
PubMed1983

Profile of serum estriol and its conjugates at delivery and in the immediate postpartum period in a patient with severe polycystic kidney disease: a comparison with normal pregnancy.

A patient with group C polycystic kidney disease had abnormally high concentrations of total serum estriol (E3) but low-normal urinary levels of E3 throughout the period of study (20 weeks of gestation until delivery by cesarean section at 33 weeks, 5 days). At delivery and at regular intervals until 6 hours thereafter serum specimens were analyzed for unconjugated E3 and its four major conjugates. Comparisons were made with levels in three normal volunteer subjects studied in the same way. In the 6 hours, total E3 declined 37% in the subject with polycystic kidney disease whereas in normal subjects the decline ranged from 84% to 99%. Unconjugated E3 was depleted from the serum in all subjects in about 2 hours. The major difference between the patient with polycystic kidney disease and the normal subjects was in the profile of E3 conjugates. In polycystic kidney disease, E3-3-glucosiduronate (E3-3G) and E3-3-sulfate-16-glucosiduronate (E3-SG) respectively made up 83% and 1.8% of the total serum estriol, whereas in the normal subjects the average values were 13% for E3-3G and 49% for E3-SG. There were no consistent dramatic changes in the percentage contribution of any conjugate to the total E3 level in either the patient with polycystic kidney disease or the normal subjects in the predelivery or postdelivery periods. The E3 profile in polycystic kidney disease is explainable in terms of impaired renal function coupled with normal enterohepatic metabolism of E3.

Estriol↗
PubMed1985

Serum unconjugated estriol level as a predictor of pulmonary maturity.

Lack of respiratory distress syndrome in infants delivered after the maternal serum estriol value attained greater than or equal to 15 ng/ml was investigated. In 91 cases after 34 weeks' gestation no lecithin-sphingomyelin ratio less than 2.0 was found where the serum estriol level was greater than or equal to 15 ng/ml and no respiratory distress syndrome in the patients delivered less than or equal to 3 days from amniocentesis.

Amniocentesis↗